Literature DB >> 2930387

Cerebellar abiotrophy in crossbred cattle.

R J Whittington1, A G Morton, D J Kennedy.   

Abstract

Cerebellar abiotrophy affected 9 of 74 calves sired by a Poll Hereford bull over 2 successive calving seasons. The disease was characterised by episodes of recumbency and ataxia, with hypermetria and wide base stance. Clinical signs commenced between birth and 8 months of age. Two calves which were affected first at 8 months of age recovered clinically 9 months later. Histological lesions were found in the cerebellar cortex of 7 calves and consisted of segmental degeneration and loss of Purkinje cells, and axonal swellings. The clinical signs and pathological findings were consistent with bovine familial convulsions and ataxia, which has not been described previously in Australia. The clinical signs were not attributable to the lesions observed in the cerebellum and an underlying electrophysiological abnormality is proposed. The aetiology of the condition is probably genetic and appears to have a multifactorial basis.

Entities:  

Mesh:

Year:  1989        PMID: 2930387     DOI: 10.1111/j.1751-0813.1989.tb09705.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

Review 1.  Cerebellar Abiotrophy Across Domestic Species.

Authors:  Erica Yuki Scott; Kevin Douglas Woolard; Carrie J Finno; James D Murray
Journal:  Cerebellum       Date:  2018-06       Impact factor: 3.847

2.  Defining Trends in Global Gene Expression in Arabian Horses with Cerebellar Abiotrophy.

Authors:  E Y Scott; M C T Penedo; J D Murray; C J Finno
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

3.  Bovine familial convulsions and ataxia in Saskatchewan and Alberta.

Authors:  Dominique Fournier; Nathan Keppie; Elemir Simko
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

4.  Congenital cerebellar cortical degeneration in Holstein cattle in Southern Brazil.

Authors:  A L Schild; F Riet-Correa; E L Portiansky; M C Méndez; D L Graça
Journal:  Vet Res Commun       Date:  2001-04       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.